MedTrace Logo

Haemodynamics of Mitral Regurgitation Reduction

NCT05403840 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-06-03

No results posted yet for this study

Summary

There is uncertainty in terms of the superiority of conventional valve surgery or percutaneous transcatheter intervention for the treatment of severe mitral regurgitation (MR) in high risk patients. The post procedural haemodynamics of the different treatment options in those at high surgical risk is poorly understood. This study seeks to characterise the physiological changes and functional outcomes of patients undergoing either surgery or transcatheter intervention.

Conditions

  • Mitral Regurgitation

Interventions

PROCEDURE

Mitral valve surgery

Surgical mitral valve repair or replacement

PROCEDURE

Transcatheter mitral valve intervention

Transcatheter mitral valve repair or replacement

Sponsors & Collaborators

  • King's College Hospital NHS Trust

    collaborator OTHER

  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER

  • Oxford University Hospitals NHS Trust

    collaborator OTHER

  • Guy's and St Thomas' NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-06
Primary Completion
2024-06-06
Completion
2025-01-06

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05403840 on ClinicalTrials.gov